newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis Rescue

EWING, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a specialty pharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Admin